NO891501L - Hetera-alifatiske karboksamider. - Google Patents

Hetera-alifatiske karboksamider.

Info

Publication number
NO891501L
NO891501L NO89891501A NO891501A NO891501L NO 891501 L NO891501 L NO 891501L NO 89891501 A NO89891501 A NO 89891501A NO 891501 A NO891501 A NO 891501A NO 891501 L NO891501 L NO 891501L
Authority
NO
Norway
Prior art keywords
formula
compounds
hetera
carboxamids
alifatic
Prior art date
Application number
NO89891501A
Other languages
English (en)
Norwegian (no)
Other versions
NO891501D0 (no
Inventor
Victor Giulio Matassa
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of NO891501D0 publication Critical patent/NO891501D0/no
Publication of NO891501L publication Critical patent/NO891501L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO89891501A 1988-04-14 1989-04-12 Hetera-alifatiske karboksamider. NO891501L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18133488A 1988-04-14 1988-04-14

Publications (2)

Publication Number Publication Date
NO891501D0 NO891501D0 (no) 1989-04-12
NO891501L true NO891501L (no) 1989-10-16

Family

ID=22663845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891501A NO891501L (no) 1988-04-14 1989-04-12 Hetera-alifatiske karboksamider.

Country Status (23)

Country Link
EP (1) EP0337766B1 (cs)
JP (1) JP2740250B2 (cs)
KR (1) KR890016016A (cs)
CN (1) CN1037895A (cs)
AT (1) ATE86612T1 (cs)
AU (1) AU622649B2 (cs)
CA (1) CA1334197C (cs)
DD (1) DD286581A5 (cs)
DE (1) DE68905216T2 (cs)
DK (1) DK176089A (cs)
ES (1) ES2053983T3 (cs)
FI (1) FI891764A7 (cs)
GB (1) GB8906032D0 (cs)
GR (1) GR3007302T3 (cs)
HU (1) HUT54995A (cs)
IE (1) IE63209B1 (cs)
IL (1) IL89925A0 (cs)
MW (1) MW2189A1 (cs)
NO (1) NO891501L (cs)
NZ (1) NZ228722A (cs)
PT (1) PT90269B (cs)
ZA (1) ZA892637B (cs)
ZM (1) ZM1689A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
EP0539329A1 (de) * 1991-10-25 1993-04-28 Ciba-Geigy Ag Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten
EP0539330B1 (de) * 1991-10-25 1995-05-17 Ciba-Geigy Ag Verfahren zur Herstellung substituierter Indole
AU714054B2 (en) * 1995-01-06 1999-12-16 Toray Industries, Inc. Benzene-fused heterocyclic derivatives and use of the same
TR200002447T2 (tr) * 1998-02-25 2000-11-21 Genetics Institute, Inc. Fosfolinaz enzimlerinin inhibitörleri
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US6797708B2 (en) 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7101875B2 (en) 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US6635771B2 (en) 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US6984735B2 (en) 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
GT200600228A (es) 2005-05-27 2006-12-26 Inhibidores de la fosfolipasa a2 citosolica
TW201309670A (zh) 2011-01-25 2013-03-01 Kissei Pharmaceutical 吲哚衍生物或其藥理學上容許之鹽

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides

Also Published As

Publication number Publication date
EP0337766A1 (en) 1989-10-18
NZ228722A (en) 1991-08-27
IL89925A0 (en) 1989-12-15
DE68905216D1 (de) 1993-04-15
DE68905216T2 (de) 1993-06-17
KR890016016A (ko) 1989-11-28
HUT54995A (en) 1991-04-29
PT90269B (pt) 1994-07-29
AU3177089A (en) 1989-10-19
FI891764A0 (fi) 1989-04-13
IE63209B1 (en) 1995-04-05
DK176089D0 (da) 1989-04-12
ZA892637B (en) 1989-12-27
DK176089A (da) 1989-10-15
FI891764A7 (fi) 1989-10-15
DD286581A5 (de) 1991-01-31
IE891188L (en) 1989-10-14
ZM1689A1 (en) 1990-01-26
GR3007302T3 (cs) 1993-07-30
AU622649B2 (en) 1992-04-16
ATE86612T1 (de) 1993-03-15
JPH01311063A (ja) 1989-12-15
NO891501D0 (no) 1989-04-12
ES2053983T3 (es) 1994-08-01
GB8906032D0 (en) 1989-04-26
CA1334197C (en) 1995-01-31
PT90269A (pt) 1989-11-10
EP0337766B1 (en) 1993-03-10
JP2740250B2 (ja) 1998-04-15
MW2189A1 (en) 1989-12-13
CN1037895A (zh) 1989-12-13

Similar Documents

Publication Publication Date Title
NO891501L (no) Hetera-alifatiske karboksamider.
EP0366061B1 (de) Die Verwendung von 4H-1-Benzopyran-4-on-Derivaten, neue 4H-1-Benzopyran-4-on-Derivate und diese enthaltende Arzneimittel
NO955074L (no) 1-substituerte istain- og oksindolderivater som inhibitorer til acetylkolinesterase
BR0209271A (pt) Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
ES554579A0 (es) Procedimiento para preparar derivados de amidoindol y amidoindazol
NO940825L (no) 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav
NO900306L (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
BR0113039A (pt) Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto
AU2014298051A1 (en) Novel quinazolinones as bromodomain inhibitors
YU20999A (sh) Heterociklični derivati koji inhibiraju faktor xa
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
BR0015821A (pt) Derivados de pirimidina
NO20052487L (no) 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
DK225081A (da) Aminopropiophenon-derivater og deres syreadditionssalte fremgangsmaader til deres fremstilling og deres anvendelse som gungicider
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DK527984A (da) 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika
EP0317295A3 (en) 4h-quinolizin-4-one compounds and pharmaceutical compositions containing them
SU1731048A3 (ru) Способ получени производных пиперидина или их фармацевтически приемлемых солей
NO158676C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater.
NO921723L (no) Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse